Cargando…
Editorial: Advances in spinal muscular atrophy
Autor principal: | Sun, Jianli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064141/ https://www.ncbi.nlm.nih.gov/pubmed/37006468 http://dx.doi.org/10.3389/fncel.2023.1178422 |
Ejemplares similares
-
SMN post-translational modifications in spinal muscular atrophy
por: Riboldi, Giulietta M., et al.
Publicado: (2023) -
History of development of the life-saving drug “Nusinersen” in spinal muscular atrophy
por: Qiu, Jiaying, et al.
Publicado: (2022) -
Commentary: Current Status of Gene Therapy for Spinal Muscular Atrophy
por: Rossoll, Wilfried, et al.
Publicado: (2022) -
The alteration of left ventricular strain in later-onset spinal muscular atrophy children
por: Cui, Yiqin, et al.
Publicado: (2022) -
NADPH oxidase 4 inhibition is a complementary therapeutic strategy for spinal muscular atrophy
por: El Khoury, Mirella, et al.
Publicado: (2023)